Live Breaking News & Updates on Vitreous Society

Stay updated with breaking news from Vitreous society. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lineage Cell Therapeutics (LCTX) Reports RG6501 Phase 1/2a Results Show Evidence of Rapid Improvement of Outer Retinal Structure

Lineage Cell Therapeutics (LCTX) Reports RG6501 Phase 1/2a Results Show Evidence of Rapid Improvement of Outer Retinal Structure
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Tel Aviv , David Schull , Adiel Barak , Brian Culley , Opregen Clinicaltrials , Tel Aviv Medical Center , Lineage Cell Therapeutics Inc , Roche Group , Exchange Commission , Lineage Cell Therapeutics , Vitreoretinal Unit Director , European Retina , Vitreous Society , Winter Meeting , Cell Therapeutics , Annual Report , Media Relations ,

Opthea to Participate at the 2023 Euretina Congress

MELBOURNE, Australia, Oct. 02, 2023 (GLOBE NEWSWIRE) Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that on October 4th, Dr. Megan Baldwin, the Company’s Chief Executive Officer will be a panelist at the inaugural Euretina Innovation Spotlight forum which is part of the Organization’s 23rd Congress being held on October 5th – 8th in Amsterdam, The Netherland ....

Noord Holland , Rudi Michelson , Hershel Berry , Megan Baldwin , Blueprint Life Science Group , Euretina Congress , Investment In Biotechnology Companies , Monsoon Communications , Opthea Limited , Company Media Enquiries , Vitreous Society , Chief Executive Officer , Euretina Innovation Spotlight , Treatment Modalities , European Retina , Biotechnology Companies , Media Enquiries , Megan Baldwin , Euretina Innovation Spotlight , Iopharmaceutical Company , Retinal Diseases , Chief Executive Officer , Novel Therapies , The Netherlands , 93rd Congress ,

Opthea to Participate at the 2023 Euretina Congress - Opthea (NASDAQ:OPT)

MELBOURNE, Australia, Oct. 02, 2023 (GLOBE NEWSWIRE) Opthea Limited (NASDAQ:OPT, ASX:OPT)), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal ....

Noord Holland , Megan Baldwin , Euretina Congress , Investment In Biotechnology Companies , Opthea Limited , Vitreous Society , Chief Executive Officer , Euretina Innovation Spotlight , Treatment Modalities , European Retina , Biotechnology Companies ,